About Eureka Therapeutics
Eureka Therapeutics is a private company based in Emeryville, California. It has reported $112,572,831 raised in five offerings on Form D since September 2014.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | May 17, 2023 | $0of $20.0M target | 0 | — | Debt, Options, Convertible promissoy notes (Notes) that is convertible into Issuer capital stock (Note Stock), and shares of Note Stock into which the Notes may convert.Rule 506(b) | Form D ↗ |
| Dec 16, 2019 | Jan 24, 2020 | $45,000,000fully sold | 20 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Jun 4, 2018 | Jun 18, 2018 | $20,000,000fully sold | 2 | $10.0M | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 13, 2016 | Dec 12, 2016amended May 30, 2017 | $26,572,831of $60.0M target | 40 | $664K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 20, 2014 | Sep 22, 2014 | $21,000,000fully sold | 28 | $750K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $112,572,831 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Eureka Therapeutics's Form D filed May 17, 2023.
VC
Vivien Chan
Executive officer
First appears on the Form D that Eureka Therapeutics filed on January 24, 2020; on 2 of its 6 filings.
CL
Cheng Liu
Executive officer and director
On every Form D that Eureka Therapeutics has filed: 6 filings, from Sep 22, 2014 to May 17, 2023.
MC
Michael Cannon
Director
First appears on the Form D that Eureka Therapeutics filed on December 12, 2016; on 5 of its 6 filings.
MS
Marvin Samson
Director
First appears on the Form D that Eureka Therapeutics filed on January 24, 2020; on 2 of its 6 filings.
WI
William Solari III
Director
First appears on the Form D that Eureka Therapeutics filed on June 18, 2018; on 3 of its 6 filings.
WC
Wai-Yan "Sandy" Chau
Director
First appears on the Form D that Eureka Therapeutics filed on June 18, 2018; on 3 of its 6 filings.
RJ
Reed Jobs
Director
First appears on the Form D that Eureka Therapeutics filed on May 17, 2023; on 1 of its 6 filings.
VS
Victor Shum
General Counsel
First appears on the Form D that Eureka Therapeutics filed on June 18, 2018; on 3 of its 6 filings.
JN
Jacqueline Northcut
Director
First appears on the Form D that Eureka Therapeutics filed on January 24, 2020; on 2 of its 6 filings.
CC
Chih-Kai "C.K. Cheng
Director
On every Form D that Eureka Therapeutics has filed: 6 filings, from Sep 22, 2014 to May 17, 2023.
Earlier filings also listed
- Bo Feng · directorLast listed on the Form D that Eureka Therapeutics filed on January 24, 2020; on 2 of its 6 filings.
- Lewis Williams · directorLast listed on the Form D that Eureka Therapeutics filed on June 18, 2018; on 1 of its 6 filings.
- Christopher Lehman · executive officerLast listed on the Form D that Eureka Therapeutics filed on June 18, 2018; on 1 of its 6 filings.
- Bijan Nejadnik · executive officerLast listed on the Form D that Eureka Therapeutics filed on June 18, 2018; on 1 of its 6 filings.
- Sandy Chau · directorLast listed on the amended Form D that Eureka Therapeutics filed on May 30, 2017; on 3 of its 6 filings.
- Qiushi Fu · directorLast listed on the amended Form D that Eureka Therapeutics filed on May 30, 2017; on 3 of its 6 filings.
- Hsing Kung · directorLast listed on the amended Form D that Eureka Therapeutics filed on May 30, 2017; on 3 of its 6 filings.